Loading icon
Press enter or spacebar to select a desired language.
Research
Press enter or spacebar to select a desired language.

PubMed COVID-19 Clinical Care

40211 - 40220 of 44782 results found

Brodalumab: 4-Year US Pharmacovigilance Report

Date
Friday, April 07, 2023 - 4:00 AM
Description
Brodalumab is an interleukin-17 receptor A antagonist approved for the treatment of moderate-to-severe psoriasis in adults without response or with loss of response to other systemic therapies. Brodalumab carries a boxed warning in the United States

'Tortured phrases' in preprints

Date
Friday, April 07, 2023 - 4:00 AM
Description
This commentary takes note of the existence of 'tortured phrases' (i.e., unspecific jargon or confusing alternative phrases), as indexed in the Tortured Phrases Detector of the Problematic Paper Screener (PPS) (sourced on January 10, 2023) in 213